Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nataliia I. Hasiuk has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ANTIBIOTIC SENSITIVITY SPECTRUM OF CLINICAL ISOLATES OF SPHINGOMONAS PAUCIMOBILIS

    by V. I. Fedorchenko, M. M. Ananieva, H. A. Loban, N. I. Hasiuk, O. I. Melashchenko

    Introduction. Sphingomonas paucimobilis is a Gram-negative, non-fermenting bacterium widely distributed in the natural environment and known for its resistance to disinfectants commonly used in healthcare settings. Human infections have been reported sporadically in both immunocompromised and immunocompetent individuals. However, data regarding the antimicrobial susceptibility patterns of this microorganism remain limited and fragmented in the literature. Objective: To determine the antibiotic susceptibility profile of clinical strains of S. paucimobilis isolated from the pharynx of children with recurrent tonsillitis and to identify antimicrobial agents suitable for empirical therapy. Materials and methods. A bacteriological approach was employed. Quantitative cultures were performed using the sector plating method on Columbia agar (bioMérieux, France). Final identification of pure isolates was carried out using the automated VITEK® 2 Compact system (bioMérieux, France). Antimicrobial susceptibility testing was performed using the standardized disk diffusion method according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines on Mueller–Hinton agar. Due to the slow growth characteristics of S. paucimobilis, inhibition zones were measured after 72 hours of incubation. Results. Three isolates of S. paucimobilis were recovered from nasopharyngeal specimens of five children, in clinically significant concentrations. Overall, the isolates demonstrated susceptibility to most tested antibiotics. The greatest variability in susceptibility was observed for the combination drug co-trimoxazole, with inhibition zone diameters differing by 1.7-fold between isolates 1 and 3. The lowest susceptibility was recorded for aztreonam, with inhibition zone diameters measuring less than 11 mm. Conclusions. For empirical treatment of infections caused by S. paucimobilis, β-lactam antibiotics combined with clavulanic acid, piperacillin–tazobactam, and carbapenems appear to be the most appropriate options. Rifampicin may be considered in cases of resistance to other antimicrobial agents.

  • Open Access

    DYSBIOTIC CHANGES IN THE PHARYNGAL MICROBIOTA: THE EPIDEMIOLOGIC ROLE OF SPHINGOMONAS PAUCIMOBILIS

    by V. I. Fedorchenko, M. M. Ananieva, G. A. Loban, N. I. Gasyuk, I. A. Zaytsev

    Introduction. Sphingomonas paucimobilis is a Gram-negative bacterium widely distributed in natural environments and healthcare settings and is known for its relative resistance to disinfectants. Human infections of various localizations have been reported sporadically. The slow growth of this microorganism on culture media, compared to most pathogenic bacteria and representatives of the normal human microbiota, may contribute to the limited data regarding its prevalence in the human microbiome and surrounding environments. Objective: To quantify the presence of S. paucimobilis in the pharyngeal microbiota of children with recurrent tonsillitis and to assess the potential epidemiological role of colonized individuals as sources of environmental contamination. Materials and methods: A bacteriological approach was employed. Quantitative cultures were performed using the sector plating method on Columbia agar supplemented with 5% sheep blood (bioMérieux, France). Final identification of isolated pure cultures was carried out using the automated VITEK® 2 Compact system (bioMérieux, France). Results. Three isolates of S. paucimobilis were recovered from nasopharyngeal specimens of five children. In two cases, S. paucimobilis was detected in association with Staphylococcus aureus, while in one case it was isolated in monoculture. The detection of S. paucimobilis in clinically significant concentrations in children with recurrent tonsillitis suggests that colonization of the pharyngeal mucosa may not be incidental. This may be related to age-associated features of the immune system and the recurrent inflammatory condition of the examined cohort. The relatively high prevalence and concentration of S. paucimobilis in the studied group indicate the potential for colonized patients to serve as reservoirs and possible sources of environmental dissemination. Conclusions. The presence of S. paucimobilis in significant concentrations among children with recurrent tonsillitis suggests a potential epidemiological role of colonized individuals as sources of environmental contamination and transmission.

  • Open Access

    OPTIMIZATION OF THE SYSTEM FOR CATAMNESTIC FOLLOW-UP OF PRETERM INFANTS AT RISK FOR DEVELOPMENTAL DISORDERS

    by V.K. Kozakevich, O.B. Kozakevich, M.M. Fastovets, N.I. Hasiuk, O.I. Melashchenko

    Introduction. Scientific literature and global statistics consistently indicate that premature birth is associated with a high risk of significant developmental disorders. This highlights the urgent need for research focused on modernizing the structural and organizational approaches to the follow-up care of prematurely born children. Such efforts are essential for preventing complications both in early childhood and later in life. Purpose: To develop a predictive model for identifying the risk of significant physical developmental delays in children born with very low and extremely low birth weight, and to justify an optimized structural and organizational model for their follow-up care system. Participants and methods. A prospective cohort study was conducted, involving 155 premature infants with a birth weight of less than 1500 g. Prediction of significant physical development delay was performed using multiple logistic regression analysis. To develop an optimized structural and organizational model of the follow-up observation system, the conceptual modeling method was used. Genetic methods included studies of polymorphism of the genes GSTP1, GSTT1, GSTM1, ACE, AGT2R1 та eNOS. Results. Based on the findings, a predictive model for the risk of significant physical developmental delay in premature infants was developed. A statistically significant association was identified between the dominant genetic model (GG + AG vs. AA) of the GSTP1 gene and physical development delay in the studied cohort. We proposed an optimized model of the follow-up monitoring system for preterm infants at risk of developmental disorders. Conclusions. Based on the findings, a predictive model for the risk of significant physical developmental delay in premature infants was developed. A statistically significant association was identified between the dominant genetic model (GG + AG vs. AA) of the GSTP1 gene and physical development delay in the studied cohort. Additionally, an optimized model of the follow-up monitoring system for preterm infants at risk of developmental disorders was proposed.

  • Open Access

    Sphingomonas paucimobilis in Children with Recurrent Tonsillitis

    by Vira Fedorchenko, Maiia Ananieva, Galina Loban', Tetyana Ivakhnyuk, Natalia Hasiuk, Nellia Bobrova

    Background: S. paucimobilis is a Gram-negative bacterium widely distributed in nat-ural environments, hospitals, and highly resistant to disinfectants. Various infections in humans have been reported as sporadic case reports. This study aimed to quantify the presence of S. paucimobilis in the fauces microbial landscape of children with re-current tonsillitis and the sensitivity of isolates to antimicrobials. Methods: The bac-teriological method of research was used. The final identification was performed on Vitec-2 compact bioMarieux automatic bacteriological analyser (France). Antimicro-bial susceptibility was determined using the measurement of the inhibition zone diameters (EUCAST standardised disk diffusion methodology) on the Mueller-Hinton (MH) agar. Results: Three isolates of S. paucimobilis were isolated from nasopharyngeal material from five children. The growth of S. paucimobilis was observed in three sectors of Columbia agar with 5% sheep blood (bioMarieux, France), as well as other bacterial species that were most abundant. The cultures were variably sensitive to most of the antibiotics used and resistant to Aztreonam. Conclusions: Human beings, as well as environmental objects, are likely to be a source of S. paucimobilis. Among the antimicrobials of choice for empirical antibiotic therapy, the best ones are the clavulanic acid-protected β-lactam antibiotics, Piperacillin Tazo-bactam, Carbopenems, and Rifampicin.

  • Open Access

    THE OUTLOOKS FOR THE SURFACTANT REPLACEMENT THERAPY OF COVID-19 INDUCED RESPIRATORY DISTRESS SYNDROME IN CHILDREN

    by Yu.I. Chernyavska, V.I. Pokhylko, Z.I. Rossokha, S.M. Tsvirenko, N.I. Hasiuk

    Nearly 6.5 million people have died worldwide from the COVID-19 pandemic. Improvement of pediatric patients survival depends on the continued provision of basic health services to women and children all over the world. The world scientific community must start more scientific clinical investigations and receive more data in order to know the impact of COVID-19 on children`s health andmortality, and to ensure that children and adolescents do not die from preventable events. Such trends in the spread of morbidity and mortality from COVID-19 require an interdisciplinary approach as soon as possible tofurther contain the spread of the disease and prevent complications in order to improve the quality of life. Insufficiently studied molecular changes in lung morpho-biology due to the action of COVID-19 complicate its clinical treatment. An in-depth genetic mechanisms investigation during pathogenetic disorders caused by virus can help in the development of new treatment methods, in articular, the use of surfactant drugs as a component of basic therapy. Recently, it became known that COVID-19-associated lung damage is characterized by typical pathophysiological changes for RDS. Diffuse alveolar damage occurs due to edema of the interstitium, the formation of hyaline membranes, as well as the proliferation of fibroblasts at the stage of recovery. When COVID-19 affects the lungs, surfactantsynthesis is dysregulated, as viral proteins suppress the expression of regulatory genes. Changes during the reparation process also lead to loss of surfactant function. Surfactant replacement therapy can be an alternative in the treatment of patients with COVID-19-associated lung damage, there are a number of studies that prove the effectiveness of such therapy in other infections. COVID-19 can be especially dangerous for children with chronic lung disease, congenital malformations, previously undiagnosed genetic defects in thesurfactant production system. However, timely use of surfactant replacement therapy can prevent one of the worst complications duringmechanical ventilation - air leakage syndrome.

  • Open Access

    NEONATAL LEUKEMIA: ASPECTS OF DIFFERENTIAL DIAGNOSIS

    by S. Tsvirenko, Н. Артьомова, O. Kaliuzhka, N. Hasiuk, L. Zhuk

    Diseases emerging in the neonatal period can manifest themselves only with a limited number of variants of clinical manifestations and laboratory syndromes. Despite this, the etiology of pathological conditions that occur in the neonatal period is very diverse and requires significant reserves of the theoretical base from a neonatologist and a pediatrician who is involved in clinical support and observation of patients of the neonatal period, as well as clinical experience regarding differential diagnosis. Neonatal leukemias refer to malignant processes with a rapid progressive course, which, due to the intensive development of the pathological process, can acquire an incurable character and threaten newborn’s life. Therefore, the issues of differential diagnosis of neonatal leukemias are relevant even despite the low incidence of this pathology among the cohort of neonatal patients.The presented article discusses the main clinical and laboratory syndromes of neonatal leukemia, which can occur as clinical manifestations of other diseases of the neonatal period; specifies the features, as well as the individual characteristics of each of the syndromes in different pathological conditions. Determination of combinations of clinical and laboratory syndromes in generalized infections in the neonatal period, non-malignant hematological diseases and neoplastic processes makes it possible to use these diphenifications in the diagnostic algorithm of neonatal conditions with the definition of further therapeutic tactics for managing a pediatric patient.

  • EFFECT OF ENOS GENE POLYMORPHISM ON THE COURSE OF EARLY ONSET BACTERIAL INFECTIONS IN PREMATURE INFANTS

    by Yuliia I. Cherniavska, Valeriy I. Pokhylko, Tetiana K. Znamenska, Olga V. Vorobiova, Nataliia I. Hasiuk

    The aim of the study was to analyze the associations between 4a/4b polymorphism of the eNOS gene and impaired systemic hemodynamics in premature infants with early neonatal sepsis. Materials and methods: We conducted a prospective cohort study, which included 120 premature babies with early neonatal sepsis, in 57 children the course of the disease was accompanied by arterial hypotension (AH) and in 61 children - not. In children of both groups, genotyping was performed to determine 4a/4b polymorphism of the eNOS gene. Results: It was shown that the heart rate, blood pressure, hourly diuresis, the level of total nitrates and nitrites in the urine, as well as a number of echocardioscopic and dopplerometric indicators in children with different eNOS gene genotypes are not different. Conclusions: There is no effect of 4a/4b polymorphism of the eNOS gene on the occurrence of hemodynamic disturbances in premature infants with sepsis.


  • Open Access

    CLINICAL CASE OF CONGENITAL LOBAR EMPHISEMA OF LEFT LUNG UPPER LOBE IN 7 MONTH OLD CHILD

    by V. Pokhylko, I. Ksonz, Y. Cherniavska, N. Hasiuk, O. Kaliuzhka

    Резюме. Проблема вродженої лобарної емфіземи залишається актуальною через складність диференційної діагностики, можливий тривалий безсимптомний перебіг, швидке погіршення стану та необхідність прийняття рішення про оперативне лікування. Лобарна, прогресуюча емфізема новонароджених (обструктивна, напружена, гіпертрофічна емфізема та ін.) – вада розвитку; що супроводжується гострим прогресуючим здуттям частки легені. Клінічна картина вродженої лобарної емфіземи широко варіює, від легкого ураження легень до гострої дихальної недостатності при народженні та рецидивуючих легеневих інфекцій, більшість пацієнтів не має симптомів у ранньому постнатальному періоді, найчастіше вони з’являються до 6 –місячного віку (у 50% випадків). Клапанний механізм призводить до гострого виникнення здуття легеневої паренхіми, збільшення частки в обсязі і здавлення нею нормально розвиненої функціонуючої легеневої тканини, а також до зсуву середостіння в «здоровий» бік і гострим порушенням кровообігу. Хірургічне втручання (лобектомія шляхом торакотомії та відео-асистована лобектомія) є лікувальним методом вибору. Дуже незначна частка пацієнтів мала добрі результати після консервативного лікування, що підтверджує наданий до розгляду клінічний випадок. У дитини Б., від народження до віку 7 місяців жодних симптомів дихальної недостатності, порушень розвитку виявлено не було. Після перенесеного гострого респіраторного вірусного захворювання виникло різке погіршення стану з клінікою легенево-серцевої недостатності, бронхообструктивного синдрому. Консервативне лікування, застосування традиційної та високочастотної ШВЛ було мало ефективним. Покращення стану відбулося лише після проведення оперативного втручання – лівобічна бокова торакотомія, верхня лобектомія, санація та дренування лівого гемотораксу. У післяопераційному періоді ускладнень не було. Дитина без ознак дихальної недостатності переведена до соматичного відділення. Наданий до розгляду випадок вказує на необхідність акцентування уваги на диференційному діагнозі вроджених вад розвитку легень при бронхообструктивних симптомах у дітей.

    • 1 January 2018
      • Vol. 71, 148-154

    [The role of genes of renin-angiotensin system in the development of adverse outcomes of treatment in severe intraventricular hemorrhages in premature infants].

    by Наталия И Гасюк, Наталия С Артемова, Елена М Ковалева, Валерий И Похилько, Галина А Соловьева

    Introduction: Intraventricular hemorrhage (IVH) causes increased morbidity and mortality in premature infants and is associated with adverse neurological outcomes. The aim of the research is to confirm the role of genes of renin-angiotensin system in the development of adverse outcomes of treatment of severe IVC in preterm. Materials and methods: A prospective study was conducted, which included 58 premature infants (average birth weight 1016.8 ± 52.59 g, gestational age 26.96 ±0.33 weeks), who were treated at medical institutions in Poltava region during 2012-2015. I/D polymorphism of ACE gene, A/C polymorphism of AGT2R1 gene and 4a/b polymorphism of the eNOS gene were studied. The distribution of the genotype was compared between groups using the χ2 analysis. Results: Out of 58 children enrolled in the study, 33 (56.9%) of infants developed ventricular dilatation, which in 8 (13.8%) of the newborns progressed to hydrocephalus. Thirty-four (58.6%) infants with severe IVHs died. The average (median) time of death of infants was 10.6 days. Among children who died, a combination of genotypes ID & DD of the gene ACE +4ab & 4AA of the eNOS gene was found significantly more often than in children who survived, and at the border of statistical significance - the isolated genotype 4ab & 4 aa of the eNOS gene. The combination of genotype ID+DD of the ACE gene and the AC + CC genotype of the AGTR1 gene was significantly more frequent among children with ventricular dilatation than in children without it. The weight at birth have negative correlation trends with lethal outcomes and do not have with ventricular dilatation and hydrocephalus. Conclusions: Lethal outcomes in children with IVH are associated with weight at birth, as well as the presence of a combination of genotypes ID+DD of the ACE gene and 4ab+4aa of the eNOS gene.

    • 18 July 2017
      • Vol. 70, 493-498

    [The dynamics of the incidence of intraventricular hemorrhages and their outcomes among prematurely born children of the poltava region in 2007-2016].

    by Елена А Калюжка, Наталия С Артемова, Наталия И Гасюк, Светлана Н Цвиренко, Валерий И Похилько

    Over the past decade, with the increase in the number of prematurely born babies with very-low-body-weight (VLBW) at birth, the number of intraventricular hemorrhages (IVH), including severe, increases, which leads to an increase in mortality and an increase in the number of posthemorrhagic hydrocephalus (PHH). To establish epidemiological trends in the IVH frequency, as well as their outcomes (PHH, mortality), among prematurely born children of the Poltava region during 2007-2016. Information base of the research is formed from materials of statistical reporting of health indicators of newborns for 2007-2016. The morbidity and mortality rates in prematurely born children with severe IVH (grade III-IV) and the incidence of PHH were studied. For 2007-2014 the average frequency of the IVH among children with VLBW was 7.0%, and among children with extremely-low-body-weight (ELBW) - 19.3%. There are stable high, with a tendency to increase, indices of the incidence of IVH among children with VLBW (from 5.4% in 2008 to 14.1% in 2014) and among children with ELBW (from 7.8% in 2008 to 45.2% in 2015). The average fatality rate among children with VLBW was 46.0%, and among children with ELBW - 63.2%. There is an increase in the mortality rate among children with ELBW and stable indicators among children with VLBW at birth. The incidence of PHH is 32.8% (20 of 61). This indicator remained stable throughout the study period. During the 2007-2016 biennium, in the Poltava region there is an increase in the incidence of IVH among prematurely born children, stable values of the mortality rate among children with VLBW and its increase among children with ELBW at birth.